Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs bioAffinity Technologies, Inc. (BIAF)

Advanced Biomed Inc. and bioAffinity Technologies, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $8.1M against $5.1M — 1.6× the size. bioAffinity Technologies, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.8×. Advanced Biomed Inc. has the higher net margin (0.00% vs −257.3%) and the higher return on invested capital (−33.4% vs −408.7%). Across the 13 metrics below, Advanced Biomed Inc. leads on 12 and bioAffinity Technologies, Inc. on 1.

Valuation

Metric ADVB BIAF Diagnostics & Research median
P/E 0.77 n/m 35.56
P/S n/m 0.22 4.37
P/B 0.41 0.35 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m 0.05 24.35
EV/Sales n/m (0.10) 5.51
Earnings yield 129.37% (2,934.19%) (1.89%)
Free cash flow yield (90.81%) (889.05%) (0.15%)

Profitability

Metric ADVB BIAF Diagnostics & Research median
Gross margin — 34.61% 50.89%
Operating margin 0.00% (209.82%) (8.57%)
Net margin 0.00% (257.33%) (6.37%)
Free cash flow margin 0.00% (195.90%) 0.00%
Return on equity 84.77% (1,860.15%) (2.92%)
Return on assets 36.47% (245.51%) (6.71%)
Return on invested capital (33.43%) (408.67%) 0.00%

Growth

Metric ADVB BIAF Diagnostics & Research median
Revenue growth (TTM) — (23.18%) 7.69%
EPS growth (last fiscal year) 266.53% 61.55% 25.92%
Revenue growth, 5-year CAGR — — 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB BIAF Diagnostics & Research median
Debt to equity 0.00 0.15 0.11
Current ratio 9.33 1.44 2.02
Net debt to EBITDA 0.06 0.57 0.70

Dividend

Metric ADVB BIAF Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric ADVB BIAF Diagnostics & Research median
Market cap 8.06m 5.08m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack